Influence of the parental virus strain on the virulence and immunogenicity of recombinant vaccinia viruses expressing HBV preS2-S protein or VZV glycoprotein I

By Kutinova L.   Ludvikova V.   Krystofova J.   Otavova M.   Simonova V.   Nemeckova S.   Hainz P.   Vonka V.  

Vaccine, Vol. 14, Iss. 11, 1996-08 ,pp. : 1045-1052

Elsevier

Access to resources Recommend Favorite

Raccoon poxvirus live recombinant feline panleukopenia virus VP2 and rabies virus glycoprotein bivalent vaccine

By Liangbiao H.   Ngichabe C.   Trimarchi C.V.   Esposito J.J.   Scott F.W.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1466-1472

Elsevier

Access to resources Recommend Favorite

Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies

By Tims T.   Briggs D.J.   Davis R.D.   Moore S.M.   Xiang Z.   Ertl H.C.J.   Fu Z.F.  

Vaccine, Vol. 18, Iss. 25, 2000-06 ,pp. : 2804-2807

Elsevier

Access to resources Recommend Favorite

Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system

By Fries L.F.   Tartaglia J.   Taylor J.   Kauffman E.K.   Meignier B.   Paoletti E.   Plotkin S.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 428-434

Elsevier

Access to resources Recommend Favorite

Influence of chicken genotype on protection against Marek's disease by a herpesvirus of turkeys recombinant expressing the glycoprotein B (gB) of M Marek's disease virus

By Ross N.   O'Sullivan G.   Coudert F.  

Vaccine, Vol. 14, Iss. 3, 1996-02 ,pp. : 187-189

Elsevier

Access to resources Recommend Favorite